• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42866
Medical Device Problem Codes Break (1069); Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 11/26/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that during the procedure, the valve broke and leaked.The valve was never implanted and there was no injury to the patient.
 
Additional Manufacturer Narrative
Patient weight provided.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported the cause of the damage was not clear.It was stated the valve broke during the patency test prior to the surgery.
 
Additional Manufacturer Narrative
The returned valve was patent.It met the requirements for valve flux, siphon, reflux, pressure flow and pre-implantation testing.However, the valve did not meet the requirement for leak testing.The valve failed leak testing due to a tear on the casing of the delta chamber.It is unknown how or when this damage occurred.The instructions for use cautions, ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting or crushing of components.Such damage may lead to loss of shunt integrity¿¿ debris was observed on the interior and exterior of the valve.The instructions for use cautions, ¿care must be taken to ensure that particulate contaminants are not introduced into shunt components during preimplantation testing or handling.Introduction of contaminants could result in improper performance of the shunt system.¿ all valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II VALVE, REGULAR
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key8200578
Report Number2021898-2018-00589
Device Sequence Number1557279
Product Code JXG
UDI-Device Identifier00613994804648
UDI-Public00613994804648
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K042465
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/29/2020
Device Model Number42866
Device Catalogue Number42866
Device Lot NumberE29991
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/18/2018
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/07/2018
Supplement Date Received by Manufacturer01/03/2019
01/18/2019
Initial Report FDA Received Date12/27/2018
Supplement Report FDA Received Date01/12/2019
02/08/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age52 YR
Patient Weight60
-
-